Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Share Buyback Programme

19 May 2025 07:01

RNS Number : 0970J
Kainos Group plc
19 May 2025
 

THE INFORMATION WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ‎UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA REGULATORY INFORMATION SERVICE, THIS INFORMATION IS ‎CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

19 May 2025

Kainos Group plc

("Kainos" or the "Company") 

 

Share Buyback Programme

Kainos Group plc, a UK-headquartered IT provider with expertise across three divisions - Digital Services, Workday Services and Workday Products, announces that, from today, it has appointed Investec Bank plc ("Investec") to manage a non-discretionary share buyback programme to purchase ordinary shares of £0.005 each in the capital of the Company ("Shares") within certain pre-set parameters, for up to a maximum amount of £30 million (excluding expenses) (the "Programme").

The Company has authorised the Programme to continue until the earlier of: (i) the date on which the maximum aggregate consideration payable by the Company has been reached and (ii) 18 November 2025.

The sole purpose of the Programme is to reduce the Company's share capital, and any Shares purchased for this purpose will be cancelled.

Rationale for Buyback Programme

As detailed in our full year results published this morning, Kainos has a strong unlevered balance sheet and continues to generate significant operating cash flow, with a net cash and treasury deposit balance of £133.7 million as of 31 March 2025.

The Programme is consistent with the Company's capital allocation policy, to enhance the growth of the business, both organically and through acquisition, and to reward shareholders through growth in earnings alongside our progressive dividend policy, while retaining a robust capital base. Where there is surplus cash over and above that needed to fund organic and inorganic growth, the Board will consider additional one-off returns of capital to shareholders.

 

In the context of the strong balance sheet position, the Board believes a share buyback to be an attractive use of capital to drive shareholder value alongside the significant ongoing organic investment.

The Board will continue to keep the capital allocation policy and further distributions to shareholders under review, with consideration of future buybacks and other potential uses of capital that may drive value for shareholders over the medium term.

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted to the Board by the Company's shareholders at the Company's annual general meeting on 24 September 2024 (the "General Authority") and, in line with the General Authority, will not exceed 12,584,171 Shares (3,993,382 Shares having already been purchased pursuant to the buyback launched in November 2024 that was completed on 9 May 2025). After the expiry of the General Authority at the conclusion of the Company's 2025 annual general meeting, the Programme will be conducted in accordance with any new authority conferred by the Company's shareholders at the 2025 annual general meeting.

The Programme will be executed in accordance with Chapter 9 of the UK Listing Rules and the terms of the General Authority. The Programme will also be conducted within the parameters of the UK version of the Market Abuse Regulation (Regulation (EU) No 596/2014) as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Investec will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Shares independently of the Company. Any purchase of Shares made in relation to the Programme will be carried out on the London Stock Exchange.

The Company will make further announcements following the completion of any purchases. There is no guarantee that the Programme will be implemented in full or that any Shares will be purchased by the Company.

The person responsible for arranging the release of this announcement on behalf of Kainos is Gráinne Burns, Company Secretary.

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Nick Prowting / Ben Griffiths

 

FTI Consulting LLP +44 20 3727 1000

Dwight Burden / Kwaku Aning

 

About Kainos Group plc

Kainos Group plc is a UK-headquartered provider of sophisticated IT services to major public sector, commercial and healthcare customers. Our expertise spans three divisions: Digital Services, Workday Services, and Workday Products.

 

· Digital Services: We develop and support custom digital service platforms that transform service delivery in public, commercial, and healthcare sectors. Our solutions ensure security, accessibility, cost-effectiveness, and improved user outcomes.

· Workday Services: Specialising in deploying Workday, Inc.'s Finance, HR, and Planning products, we are a respected partner in Europe and North America. Experienced in complex deployments, we are trusted to launch, test, expand, and support Workday systems.

· Workday Products: Our established product suite, incorporating Smart Test, Smart Audit, and Smart Shield, complements Workday by enhancing system security and compliance. Our Employee Document Management product, launched in October 2023, improves document generation and storage within Workday while supporting an organisation's global compliance requirements. Over 500 global customers use one or more of our products.

 

Our people are central to our success. We employ more than 3,000 people in 20 countries across Europe, Asia and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKSKFSFSEFA
Date   Source Headline
2nd Aug 20194:52 pmRNSHolding(s) in Company
1st Aug 20192:35 pmRNSTotal Voting Rights
31st Jul 201911:30 amRNSAnnual Report 2019
26th Jul 201911:36 amRNSHolding(s) in Company
24th Jul 20197:00 amRNSBoard Change
18th Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 20191:24 pmRNSDirector/PDMR Shareholding
4th Jul 20193:10 pmRNSHolding(s) in Company
1st Jul 20192:09 pmRNSTotal Voting Rights
25th Jun 20198:33 amRNSHolding(s) in Company
24th Jun 20191:43 pmRNSHolding(s) in Company
17th Jun 20194:40 pmRNSHolding(s) in Company
17th Jun 20194:26 pmRNSDirector/PDMR Shareholding
31st May 20194:06 pmRNSTotal Voting Rights
29th May 20197:55 amRNSHolding(s) in Company
29th May 20197:44 amRNSHolding(s) in Company
28th May 20197:00 amRNSPreliminary Results
1st May 20196:10 pmRNSTotal Voting Rights
1st May 20196:10 pmRNSBlock listing Interim Review
16th Apr 20197:00 amRNSTrading Statement
1st Apr 20193:29 pmRNSTotal Voting Rights
21st Mar 20194:28 pmRNSHolding(s) in Company
7th Mar 201911:31 amRNSDirector/PDMR Shareholding
28th Feb 201912:11 pmRNSTotal Voting Rights
25th Feb 20194:47 pmRNSHolding(s) in Company
12th Feb 20197:00 amRNSKainos announces site purchase for new Belfast HQ
6th Feb 20195:11 pmRNSAdmission of Shares to Trading
6th Feb 20193:59 pmRNSHolding(s) in Company
5th Feb 20194:01 pmRNSHolding(s) in Company
4th Feb 20194:11 pmRNSTotal Voting Rights
4th Feb 20197:00 amRNSTrading Update
6th Dec 20184:35 pmRNSPrice Monitoring Extension
5th Dec 20181:02 pmRNSDirector/PDMR Shareholding
3rd Dec 20181:38 pmRNSTotal Voting Rights
26th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSInterim Results
23rd Nov 20184:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20185:02 pmRNSHolding(s) in Company
1st Nov 20183:57 pmRNSAdmission of Shares to Trading
1st Nov 20183:53 pmRNSBlock Admission
1st Nov 20183:49 pmRNSTotal Voting Rights
18th Oct 201812:07 pmRNSSecond Price Monitoring Extn
18th Oct 201812:02 pmRNSPrice Monitoring Extension
3rd Oct 20187:00 amRNSChange of Registered Office
1st Oct 20184:47 pmRNSTotal Voting Rights
20th Sep 20183:15 pmRNSAGM Statement
14th Sep 20184:06 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.